Search results

Awaiting development Reference number: GID-TA11813 Expected publication date: TBC

Result type

Technology appraisal guidance

Status

Awaiting development

This guideline covers care for people with a family history of breast, ovarian or another related (prostate or pancreatic) cancer. It aims to improve the long-term health of these families by describing strategies to reduce the risk of and promote early detection of breast cancer (including genetic testing and mammography). It also includes advice on treatments (tamoxifen, raloxifene) and surgery (mastectomy).

Result type

Clinical guideline

Last updated

14 November 2023

Evidence-based recommendations on photodynamic therapy for early-stage oesophageal cancer. This involves injecting a photosensitising agent into the tumour which is then activated by a light to destroy the tumour cells.

Result type

HealthTech guidance

Published

13 December 2006

Evidence-based recommendations on stent placement for vena caval obstruction. This involves using a catheter to position a stent, which may be self-expanding or balloon-dilated, across the area of narrowing to relieve it.

Result type

HealthTech guidance

Published

28 July 2004

Awaiting development Reference number: GID-TA11222 Expected publication date: TBC

Result type

Technology appraisal guidance

Status

Awaiting development

Evidence-based recommendations on capecitabine for treating advanced gastric cancer in adults.

Result type

Technology appraisal guidance

Published

28 July 2010

Evidence-based recommendations on tenofovir disoproxil for treating chronic hepatitis B.

Result type

Technology appraisal guidance

Published

22 July 2009

Evidence-based recommendations on photodynamic therapy for brain tumours. This involves giving the patient a drug that makes the tissue sensitive to light and then activating it with a laser light source to destroy the tumour cells.

Result type

HealthTech guidance

Published

25 March 2009

Evidence-based recommendations on irreversible electroporation for primary liver cancer in adults. This involves passing short electrical pulses of high-voltage current into the cancer cells.

Result type

HealthTech guidance

Published

27 November 2019

Awaiting development Reference number: GID-TA11653 Expected publication date: TBC

Result type

Technology appraisal guidance

Status

Awaiting development

Our centralised approach to prioritising our guidance topics ensures that we produce guidance that's relevant, timely, accessible, and has demonstrable impact.

Discontinued Reference number: GID-TA10166

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on erdafitinib (Balversa) for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitor in adults.

Result type

Technology appraisal guidance

Published

12 May 2025

Evidence-based recommendations on laparoscopic liver resection. This involves making small incisions (keyhole surgery) to remove the parts of the liver that are benign or cancerous.

Result type

HealthTech guidance

Published

27 July 2005

Evidence-based recommendations on cryotherapy for treating recurrent prostate cancer. This involves putting special needles or probes into the prostate and using Argon gas to freeze and destroy the cancerous prostate tissue.

Result type

HealthTech guidance

Published

25 May 2005